A Comparison of Outcome of Surgical Treatment of Migraine Headaches Using a Constellation of Symptoms versus Botulinum Toxin Type A to Identify the Trigger Sites

Liu, Mengyuan T.; Armijo, Bryan S.; Guyuron, Bahman

doi:10.1097/prs.0b013e31823aecb7

Cited by 81 publications

(82 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…7 Our current algorithm has been very helpful in detecting migraine headache trigger sites reliably. First, we ask the patients to identify the independent migraine headache trigger sites.…”

Section: Discussionmentioning

confidence: 99%

Emergence of Secondary Trigger Sites after Primary Migraine Surgery

Punjabi

Brown

Guyuron

2016

Plastic &Amp; Reconstructive Surgery

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Emergence of Secondary Trigger Sites after Primary Migraine Surgery

Punjabi

Brown

Guyuron

2016

Plastic &Amp; Reconstructive Surgery

Self Cite

View full text Add to dashboard Cite

show abstract

“…7,9,10,12,13 Although response to Botox is a positive prognostic indicator for surgical success, 18 recent data also suggest that a constellation of symptoms obtained through a thorough history and physical is equally as efficacious in predicting which sites will be amenable to surgical decompression. 19 As an alternative, many surgeons also use a diagnostic peripheral nerve block with a local anesthetic to identify trigger sites that will be amenable to surgical decompression. The 4 sites addressed include a frontal trigger, temporal trigger, occipital trigger, and a nasoseptal trigger in the setting of septal deviation or turbinate hypertrophy, which results in aberrant contact points.…”

Section: Surgical Techniquementioning

confidence: 99%

A Review of Current Evidence in the Surgical Treatment of Migraine Headaches

Janis¹,

Barker²,

Javadi³

et al. 2014

Plastic and Reconstructive Surgery

Self Cite

107

123

View full text Add to dashboard Cite

Migraines affect 18% of women and 6% of men and result in an estimated $1 billion in medical costs and $16 billion productivity loss in the United States annually. Migraine headaches persist as a problem of this scale because pharmacologic treatments for migraines are frequently incompletely effective, resulting in a population of patients with significant residual disability. In the last decade, novel approaches to the treatment of migraines have been developed based on the theory that extracranial sensory branches of the trigeminal and cervical spinal nerves can be irritated, entrapped, or compressed at points throughout their anatomic course, ultimately leading to the cascade of physiologic events that results in migraine. Botulinum toxin (Botox) injection and surgical decompression of these trigger points have been shown to reduce or eliminate migraines in patients who are incompletely treated by traditional medical management. Despite the recent advances made with Botox, this treatment strategy most commonly results in only temporary migraine prevention. However, the evidence supporting the efficacy and safety of permanent surgical decompression of peripheral trigger points is accumulating rapidly, and the overall success rate of surgery has approached 90%. In addition, an abundance of literature investigating the precise anatomical dissections associated with trigger points has been published concurrently. This article reviews the most up-to-date clinical and anatomic evidence available and seeks to provide a comprehensive, concise resource for the current state of the art in the surgical treatment of migraine headaches.

show abstract

“…More recently, the same group published several retrospective studies aiming at identifying predictors of favorable outcome (76,78,80) or added value of additional surgical procedures like supraorbital foraminotomy (79) or ligation of the occipital artery (81). Only three other groups have published retrospective studies on the effects of surgery in the frontal area in migraine.…”

Section: Surgical Decompressionsmentioning

confidence: 99%

Targeting pericranial nerve branches to treat migraine: Current approaches and perspectives

et al. 2015

View full text Add to dashboard Cite

Background: Migraine is a highly prevalent neurological disorders and a major individual and societal burden. Migraine is not curable at the present time, but it is amenable to acute symptomatic and preventive pharmacotherapies. Summary: Since the latter are frequently unsatisfactory, other treatment strategies have been used or are being explored. In particular, interventions targeting pericranial nerves are now part of the migraine armamentarium. We will critically review some of them, such as invasive and noninvasive neurostimulation, therapeutic blocks and surgical decompressions. Conclusions: Although current knowledge on migraine pathophysiology suggests a central nervous system dysfunction, there is some evidence that interventions targeting peripheral nerves are able to modulate neuronal circuits involved in pain control and that they could be useful in some selected patients. Larger, well-designed and comparative trials are needed to appraise the respective advantages, disadvantages and indications of most interventions discussed here.

show abstract

A Comparison of Outcome of Surgical Treatment of Migraine Headaches Using a Constellation of Symptoms versus Botulinum Toxin Type A to Identify the Trigger Sites

Abstract: Therapeutic, III.

Cited by 81 publications

References 22 publications

Emergence of Secondary Trigger Sites after Primary Migraine Surgery

Emergence of Secondary Trigger Sites after Primary Migraine Surgery

A Review of Current Evidence in the Surgical Treatment of Migraine Headaches

Targeting pericranial nerve branches to treat migraine: Current approaches and perspectives

Contact Info

Product

Resources

About